25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Biotechnology Assets S.A.
Buy, Hold or Sell?

Let's analyze Biotechnology Assets S.A. together

I guess you are interested in Biotechnology Assets S.A.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biotechnology Assets S.A.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Biotechnology Assets S.A.

I send you an email if I find something interesting about Biotechnology Assets S.A..

1. Quick Overview

1.1. Quick analysis of Biotechnology Assets S.A. (30 sec.)










1.2. What can you expect buying and holding a share of Biotechnology Assets S.A.? (30 sec.)

How much money do you get?

How much money do you get?
€0.00
When do you have the money?
1 year
How often do you get paid?
30.0%

What is your share worth?

Current worth
€0.10
Expected worth in 1 year
€0.26
How sure are you?
70.0%

+ What do you gain per year?

Total Gains per Share
€0.16
Return On Investment
46.9%

For what price can you sell your share?

Current Price per Share
€0.35
Expected price per share
€0.236 - €0.39
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Biotechnology Assets S.A. (5 min.)




Live pricePrice per Share (EOD)
€0.35
Intrinsic Value Per Share
€-9.74 - €-2.72
Total Value Per Share
€-9.64 - €-2.62

2.2. Growth of Biotechnology Assets S.A. (5 min.)




Is Biotechnology Assets S.A. growing?

Current yearPrevious yearGrowGrow %
How rich?$6.8m$4m$2.7m40.7%

How much money is Biotechnology Assets S.A. making?

Current yearPrevious yearGrowGrow %
Making money$1.6m-$2m$3.6m223.5%
Net Profit Margin40.3%-74.4%--

How much money comes from the company's main activities?

2.3. Financial Health of Biotechnology Assets S.A. (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Biotechnology Assets S.A.?

Welcome investor! Biotechnology Assets S.A.'s management wants to use your money to grow the business. In return you get a share of Biotechnology Assets S.A..

First you should know what it really means to hold a share of Biotechnology Assets S.A.. And how you can make/lose money.

Speculation

The Price per Share of Biotechnology Assets S.A. is €0.347. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biotechnology Assets S.A..
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biotechnology Assets S.A., you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €0.10. Based on the TTM, the Book Value Change Per Share is €0.04 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biotechnology Assets S.A..

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps0.037.3%0.037.3%-0.03-9.0%-0.07-20.4%-0.06-18.0%
Usd Book Value Change Per Share0.0412.3%0.0412.3%-0.01-2.2%-0.05-13.6%0.013.0%
Usd Dividend Per Share0.000.0%0.000.0%0.95273.0%0.1955.5%0.1027.8%
Usd Total Gains Per Share0.0412.3%0.0412.3%0.94270.9%0.1541.9%0.1130.8%
Usd Price Per Share0.42-0.42-0.24-0.77-2.41-
Price to Earnings Ratio16.43-16.43--7.73--3.73--364.31-
Price-to-Total Gains Ratio9.73-9.73-0.26-2.20-110.59-
Price to Book Ratio3.96-3.96-3.88-8.36-19.49-
Price-to-Total Gains Ratio9.73-9.73-0.26-2.20-110.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.3637948
Number of shares2748
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.19
Usd Book Value Change Per Share0.04-0.05
Usd Total Gains Per Share0.040.15
Gains per Quarter (2748 shares)117.30399.79
Gains per Year (2748 shares)469.201,599.14
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
104694592117-5181589
209389284234-10353188
30140813976350-15534787
40187718668467-20716386
502346233510584-25887985
602815280412701-31069584
703284327314817-362311183
803754374216934-414112782
904223421119051-465914381
1004692468021168-517615980

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%1.02.00.033.3%1.04.00.020.0%2.08.00.020.0%2.08.00.020.0%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%6.04.00.060.0%6.04.00.060.0%
Dividend per Share0.00.01.00.0%2.00.01.066.7%2.00.03.040.0%3.00.07.030.0%3.00.07.030.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%3.02.00.060.0%7.03.00.070.0%7.03.00.070.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Biotechnology Assets S.A. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0410.0410%-0.007+118%-0.045+210%0.010+307%
Book Value Per Share--0.1000.1000%0.059+69%0.080+25%0.120-17%
Current Ratio--1.0411.0410%0.883+18%0.913+14%1.211-14%
Debt To Asset Ratio--0.6070.6070%0.790-23%0.781-22%0.665-9%
Debt To Equity Ratio--1.5081.5080%3.627-58%4.747-68%3.051-51%
Dividend Per Share----0%0.904-100%0.184-100%0.092-100%
Enterprise Value--16134484.60016134484.6000%1194097.000+1251%21163482.120-24%128434065.060-87%
Eps--0.0240.0240%-0.030+223%-0.068+380%-0.060+348%
Ev To Ebitda Ratio--3.1643.1640%2.651+19%-117.716+3820%470.130-99%
Ev To Sales Ratio--4.1284.1280%0.457+804%3.836+8%73.883-94%
Free Cash Flow Per Share---0.004-0.0040%-3.266+76548%-0.704+16429%-0.395+9170%
Free Cash Flow To Equity Per Share---0.005-0.0050%-1.509+28938%-0.448+8526%-0.224+4212%
Gross Profit Margin--0.9750.9750%1.007-3%1.002-3%1.010-3%
Intrinsic Value_10Y_max---2.720--------
Intrinsic Value_10Y_min---9.743--------
Intrinsic Value_1Y_max---0.613--------
Intrinsic Value_1Y_min---1.081--------
Intrinsic Value_3Y_max---1.582--------
Intrinsic Value_3Y_min---3.176--------
Intrinsic Value_5Y_max---2.238--------
Intrinsic Value_5Y_min---5.177--------
Market Cap22654797.200-14%25853889.60025853889.6000%15016148.000+72%48064731.120-46%149776283.160-83%
Net Profit Margin--0.4030.4030%-0.744+285%-0.994+347%-0.613+252%
Operating Margin--0.6740.6740%-0.649+196%-0.237+135%-0.790+217%
Operating Ratio--0.3300.3300%1.653-80%1.216-73%1.277-74%
Pb Ratio3.468-14%3.9583.9580%3.876+2%8.360-53%19.494-80%
Pe Ratio14.395-14%16.42816.4280%-7.727+147%-3.735+123%-364.308+2318%
Price Per Share0.347-14%0.3960.3960%0.230+72%0.736-46%2.294-83%
Price To Free Cash Flow Ratio-81.426+12%-92.924-92.9240%-0.070-100%-21.681-77%-142.627+53%
Price To Total Gains Ratio8.523-14%9.7269.7260%0.257+3691%2.202+342%110.591-91%
Quick Ratio--0.9850.9850%0.869+13%0.854+15%1.233-20%
Return On Assets--0.0950.0950%-0.105+211%-0.139+247%-0.091+196%
Return On Equity--0.2350.2350%-0.483+305%-0.876+472%-0.519+320%
Total Gains Per Share--0.0410.0410%0.897-95%0.139-71%0.102-60%
Usd Book Value--6848070.1706848070.1700%4061202.806+69%5482812.238+25%8237635.256-17%
Usd Book Value Change Per Share--0.0430.0430%-0.007+118%-0.047+210%0.010+307%
Usd Book Value Per Share--0.1050.1050%0.062+69%0.084+25%0.126-17%
Usd Dividend Per Share----0%0.947-100%0.193-100%0.096-100%
Usd Enterprise Value--16915393.65516915393.6550%1251891.295+1251%22187794.655-24%134650273.809-87%
Usd Eps--0.0250.0250%-0.031+223%-0.071+380%-0.063+348%
Usd Free Cash Flow---291693.292-291693.2920%-223576328.126+76548%-48213508.710+16429%-27040167.412+9170%
Usd Free Cash Flow Per Share---0.004-0.0040%-3.424+76548%-0.738+16429%-0.414+9170%
Usd Free Cash Flow To Equity Per Share---0.005-0.0050%-1.582+28938%-0.470+8526%-0.235+4212%
Usd Market Cap23751289.384-14%27105217.85727105217.8570%15742929.563+72%50391064.106-46%157025455.265-83%
Usd Price Per Share0.364-14%0.4150.4150%0.241+72%0.772-46%2.405-83%
Usd Profit--1649941.5161649941.5160%-2037421.056+223%-4627950.952+380%-4086120.536+348%
Usd Revenue--4097599.0604097599.0600%2740260.742+50%11314175.959-64%8796949.422-53%
Usd Total Gains Per Share--0.0430.0430%0.940-95%0.145-71%0.107-60%
 EOD+3 -5MRQTTM+0 -0YOY+32 -85Y+28 -1210Y+19 -21

3.3 Fundamental Score

Let's check the fundamental score of Biotechnology Assets S.A. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1514.395
Price to Book Ratio (EOD)Between0-13.468
Net Profit Margin (MRQ)Greater than00.403
Operating Margin (MRQ)Greater than00.674
Quick Ratio (MRQ)Greater than10.985
Current Ratio (MRQ)Greater than11.041
Debt to Asset Ratio (MRQ)Less than10.607
Debt to Equity Ratio (MRQ)Less than11.508
Return on Equity (MRQ)Greater than0.150.235
Return on Assets (MRQ)Greater than0.050.095
Total7/10 (70.0%)

3.4 Technical Score

Let's check the technical score of Biotechnology Assets S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.259
Ma 20Greater thanMa 500.334
Ma 50Greater thanMa 1000.317
Ma 100Greater thanMa 2000.309
OpenGreater thanClose0.337
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Biotechnology Assets S.A.

Biotechnology Assets, S.A. develops and markets biotechnological assets for application in the biopharmaceutical, agrochemical, cosmetic, veterinary, and chemical industry sectors in Spain and internationally. The company was founded in 1954 and is based in Cádiz, Spain.

Fundamental data was last updated by Penke on 2025-02-10 22:28:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is efficient in making profit.
Using its investors money, the company is efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very efficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Biotechnology Assets S.A. earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Biotechnology Assets S.A. to the Biotechnology industry mean.
  • A Net Profit Margin of 40.3% means that €0.40 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biotechnology Assets S.A.:

  • The MRQ is 40.3%. The company is making a huge profit. +2
  • The TTM is 40.3%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ40.3%TTM40.3%0.0%
TTM40.3%YOY-74.4%+114.6%
TTM40.3%5Y-99.4%+139.6%
5Y-99.4%10Y-61.3%-38.1%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ40.3%-99.4%+139.7%
TTM40.3%-211.5%+251.8%
YOY-74.4%-210.1%+135.7%
5Y-99.4%-346.2%+246.8%
10Y-61.3%-489.2%+427.9%
4.3.1.2. Return on Assets

Shows how efficient Biotechnology Assets S.A. is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biotechnology Assets S.A. to the Biotechnology industry mean.
  • 9.5% Return on Assets means that Biotechnology Assets S.A. generated €0.09 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biotechnology Assets S.A.:

  • The MRQ is 9.5%. Using its assets, the company is efficient in making profit. +1
  • The TTM is 9.5%. Using its assets, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ9.5%TTM9.5%0.0%
TTM9.5%YOY-10.5%+20.0%
TTM9.5%5Y-13.9%+23.4%
5Y-13.9%10Y-9.1%-4.8%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.5%-12.0%+21.5%
TTM9.5%-12.1%+21.6%
YOY-10.5%-11.4%+0.9%
5Y-13.9%-12.8%-1.1%
10Y-9.1%-14.6%+5.5%
4.3.1.3. Return on Equity

Shows how efficient Biotechnology Assets S.A. is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biotechnology Assets S.A. to the Biotechnology industry mean.
  • 23.5% Return on Equity means Biotechnology Assets S.A. generated €0.24 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biotechnology Assets S.A.:

  • The MRQ is 23.5%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 23.5%. Using its investors money, the company is efficient in making profit. +1
Trends
Current periodCompared to+/- 
MRQ23.5%TTM23.5%0.0%
TTM23.5%YOY-48.3%+71.8%
TTM23.5%5Y-87.6%+111.2%
5Y-87.6%10Y-51.9%-35.7%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ23.5%-15.4%+38.9%
TTM23.5%-16.1%+39.6%
YOY-48.3%-14.7%-33.6%
5Y-87.6%-18.6%-69.0%
10Y-51.9%-19.5%-32.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Biotechnology Assets S.A..

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Biotechnology Assets S.A. is operating .

  • Measures how much profit Biotechnology Assets S.A. makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biotechnology Assets S.A. to the Biotechnology industry mean.
  • An Operating Margin of 67.4% means the company generated €0.67  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biotechnology Assets S.A.:

  • The MRQ is 67.4%. The company is operating very efficient. +2
  • The TTM is 67.4%. The company is operating very efficient. +2
Trends
Current periodCompared to+/- 
MRQ67.4%TTM67.4%0.0%
TTM67.4%YOY-64.9%+132.3%
TTM67.4%5Y-23.7%+91.1%
5Y-23.7%10Y-79.0%+55.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ67.4%-201.5%+268.9%
TTM67.4%-312.9%+380.3%
YOY-64.9%-215.2%+150.3%
5Y-23.7%-371.8%+348.1%
10Y-79.0%-492.1%+413.1%
4.3.2.2. Operating Ratio

Measures how efficient Biotechnology Assets S.A. is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.33 means that the operating costs are €0.33 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Biotechnology Assets S.A.:

  • The MRQ is 0.330. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.330. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.330TTM0.3300.000
TTM0.330YOY1.653-1.322
TTM0.3305Y1.216-0.886
5Y1.21610Y1.277-0.061
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3302.129-1.799
TTM0.3303.198-2.868
YOY1.6533.358-1.705
5Y1.2164.842-3.626
10Y1.2776.500-5.223
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Biotechnology Assets S.A..

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Biotechnology Assets S.A. is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 1.04 means the company has €1.04 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Biotechnology Assets S.A.:

  • The MRQ is 1.041. The company is just able to pay all its short-term debts.
  • The TTM is 1.041. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.041TTM1.0410.000
TTM1.041YOY0.883+0.158
TTM1.0415Y0.913+0.127
5Y0.91310Y1.211-0.297
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0413.608-2.567
TTM1.0413.873-2.832
YOY0.8834.591-3.708
5Y0.9135.977-5.064
10Y1.2116.216-5.005
4.4.3.2. Quick Ratio

Measures if Biotechnology Assets S.A. is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biotechnology Assets S.A. to the Biotechnology industry mean.
  • A Quick Ratio of 0.98 means the company can pay off €0.98 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biotechnology Assets S.A.:

  • The MRQ is 0.985. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.985. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.985TTM0.9850.000
TTM0.985YOY0.869+0.115
TTM0.9855Y0.854+0.130
5Y0.85410Y1.233-0.379
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9853.066-2.081
TTM0.9853.360-2.375
YOY0.8694.394-3.525
5Y0.8546.000-5.146
10Y1.2336.483-5.250
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Biotechnology Assets S.A..

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Biotechnology Assets S.A. assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biotechnology Assets S.A. to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.61 means that Biotechnology Assets S.A. assets are financed with 60.7% credit (debt) and the remaining percentage (100% - 60.7%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biotechnology Assets S.A.:

  • The MRQ is 0.607. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.607. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.607TTM0.6070.000
TTM0.607YOY0.790-0.184
TTM0.6075Y0.781-0.175
5Y0.78110Y0.665+0.116
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6070.342+0.265
TTM0.6070.345+0.262
YOY0.7900.315+0.475
5Y0.7810.363+0.418
10Y0.6650.384+0.281
4.5.4.2. Debt to Equity Ratio

Measures if Biotechnology Assets S.A. is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biotechnology Assets S.A. to the Biotechnology industry mean.
  • A Debt to Equity ratio of 150.8% means that company has €1.51 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biotechnology Assets S.A.:

  • The MRQ is 1.508. The company is just able to pay all its debts with equity.
  • The TTM is 1.508. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.508TTM1.5080.000
TTM1.508YOY3.627-2.120
TTM1.5085Y4.747-3.239
5Y4.74710Y3.051+1.696
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5080.387+1.121
TTM1.5080.428+1.080
YOY3.6270.391+3.236
5Y4.7470.450+4.297
10Y3.0510.495+2.556
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Biotechnology Assets S.A. generates.

  • Above 15 is considered overpriced but always compare Biotechnology Assets S.A. to the Biotechnology industry mean.
  • A PE ratio of 16.43 means the investor is paying €16.43 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biotechnology Assets S.A.:

  • The EOD is 14.395. Based on the earnings, the company is underpriced. +1
  • The MRQ is 16.428. Based on the earnings, the company is fair priced.
  • The TTM is 16.428. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD14.395MRQ16.428-2.033
MRQ16.428TTM16.4280.000
TTM16.428YOY-7.727+24.155
TTM16.4285Y-3.735+20.163
5Y-3.73510Y-364.308+360.574
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD14.395-2.230+16.625
MRQ16.428-2.713+19.141
TTM16.428-3.224+19.652
YOY-7.727-3.410-4.317
5Y-3.735-6.128+2.393
10Y-364.308-6.735-357.573
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biotechnology Assets S.A.:

  • The EOD is -81.426. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -92.924. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -92.924. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-81.426MRQ-92.924+11.498
MRQ-92.924TTM-92.9240.000
TTM-92.924YOY-0.070-92.853
TTM-92.9245Y-21.681-71.242
5Y-21.68110Y-142.627+120.946
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-81.426-3.041-78.385
MRQ-92.924-3.582-89.342
TTM-92.924-3.804-89.120
YOY-0.070-4.446+4.376
5Y-21.681-8.265-13.416
10Y-142.627-9.219-133.408
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Biotechnology Assets S.A. is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.96 means the investor is paying €3.96 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Biotechnology Assets S.A.:

  • The EOD is 3.468. Based on the equity, the company is fair priced.
  • The MRQ is 3.958. Based on the equity, the company is fair priced.
  • The TTM is 3.958. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.468MRQ3.958-0.490
MRQ3.958TTM3.9580.000
TTM3.958YOY3.876+0.082
TTM3.9585Y8.360-4.402
5Y8.36010Y19.494-11.134
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD3.4681.960+1.508
MRQ3.9582.242+1.716
TTM3.9582.424+1.534
YOY3.8762.470+1.406
5Y8.3603.767+4.593
10Y19.4944.507+14.987
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Income before Tax  -9,9948,439-1,555-1,356-2,910867-2,0434,3652,322
Net Income  -10,0821,476-8,6075,594-3,0131,070-1,9433,5171,574
EBIT  -2,5421,321-1,221-834-2,056358-1,6974,3312,633



6.2. Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets16,607
Total Liabilities10,075
Total Stockholder Equity6,683
 As reported
Total Liabilities 10,075
Total Stockholder Equity+ 6,683
Total Assets = 16,607

Assets

Total Assets16,607
Total Current Assets3,760
Long-term Assets12,847
Total Current Assets
Cash And Cash Equivalents 311
Short-term Investments 45
Net Receivables 3,155
Other Current Assets 188
Total Current Assets  (as reported)3,760
Total Current Assets  (calculated)3,699
+/- 61
Long-term Assets
Property Plant Equipment 2,445
Goodwill 2,099
Intangible Assets 4,975
Long-term Assets Other 490
Long-term Assets  (as reported)12,847
Long-term Assets  (calculated)10,008
+/- 2,839

Liabilities & Shareholders' Equity

Total Current Liabilities3,612
Long-term Liabilities6,463
Total Stockholder Equity6,683
Total Current Liabilities
Short-term Debt 1,972
Accounts payable 311
Other Current Liabilities 653
Total Current Liabilities  (as reported)3,612
Total Current Liabilities  (calculated)2,936
+/- 676
Long-term Liabilities
Long-term Liabilities  (as reported)6,463
Long-term Liabilities  (calculated)0
+/- 6,463
Total Stockholder Equity
Common Stock2,892
Retained Earnings -20,650
Accumulated Other Comprehensive Income 1,178
Other Stockholders Equity 23,263
Total Stockholder Equity (as reported)6,683
Total Stockholder Equity (calculated)6,683
+/-0
Other
Cash and Short Term Investments 356
Common Stock Shares Outstanding 57,726
Current Deferred Revenue-751
Liabilities and Stockholders Equity 16,607
Net Debt 6,815
Net Working Capital 148
Short Long Term Debt Total 7,126



6.3. Balance Sheets Structured

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-31
> Total Assets 
5,030
7,295
7,613
9,247
14,683
14,799
15,972
17,584
79,239
92,667
20,211
19,876
18,475
16,607
16,60718,47519,87620,21192,66779,23917,58415,97214,79914,6839,2477,6137,2955,030
   > Total Current Assets 
1,229
2,263
1,720
1,137
4,176
3,300
1,739
3,067
20,611
30,413
3,366
4,404
3,122
3,760
3,7603,1224,4043,36630,41320,6113,0671,7393,3004,1761,1371,7202,2631,229
       Cash And Cash Equivalents 
21
1,419
117
576
1,120
445
159
505
3,951
2,621
556
1,677
692
311
3116921,6775562,6213,9515051594451,1205761171,41921
       Short-term Investments 
698
111
436
172
893
890
940
883
1,150
1,142
26
25
87
45
458725261,1421,150883940890893172436111698
       Net Receivables 
0
0
1,065
0
2,135
0
574
3,246
-4,031
19,608
2,698
2,619
2,207
3,155
3,1552,2072,6192,69819,608-4,0313,24657402,13501,06500
       Other Current Assets 
0
733
10
347
2,135
1,911
0
4,196
12,984
2,169
68
2,702
2,371
188
1882,3712,702682,16912,9844,19601,9112,135347107330
   > Long-term Assets 
3,800
5,032
5,893
8,110
10,507
11,499
14,233
14,517
58,628
62,254
16,845
15,472
15,353
12,847
12,84715,35315,47216,84562,25458,62814,51714,23311,49910,5078,1105,8935,0323,800
       Property Plant Equipment 
1,752
2,349
2,266
3,117
3,276
3,125
3,181
3,129
37,370
41,247
2,696
2,560
2,529
2,445
2,4452,5292,5602,69641,24737,3703,1293,1813,1253,2763,1172,2662,3491,752
       Goodwill 
0
0
0
0
2,040
2,040
2,759
4,822
6,656
4,649
4,012
3,374
2,737
2,099
2,0992,7373,3744,0124,6496,6564,8222,7592,0402,0400000
       Intangible Assets 
0
0
0
2,120
2,840
3,451
4,720
2,940
7,439
9,152
6,439
5,844
6,392
4,975
4,9756,3925,8446,4399,1527,4392,9404,7203,4512,8402,120000
       Long-term Assets Other 
1,397
111
436
173
894
916
998
883
2,220
2,470
269
269
332
490
4903322692692,4702,2208839989168941734361111,397
> Total Liabilities 
2,839
4,693
4,757
5,005
7,006
7,228
8,016
9,557
58,044
85,107
16,368
15,537
14,601
10,075
10,07514,60115,53716,36885,10758,0449,5578,0167,2287,0065,0054,7574,6932,839
   > Total Current Liabilities 
-290
564
627
1,082
1,907
1,674
2,174
1,988
19,886
28,963
9,515
3,553
3,535
3,612
3,6123,5353,5539,51528,96319,8861,9882,1741,6741,9071,082627564-290
       Short-term Debt 
0
0
0
102
889
841
142
5,786
6,592
7,978
960
481
562
1,972
1,9725624819607,9786,5925,786142841889102000
       Accounts payable 
-625
36
15
20
15
22
27
5,288
5,290
3,442
388
303
396
311
3113963033883,4425,2905,288272215201536-625
       Other Current Liabilities 
335
528
612
960
1,003
812
2,005
-9,085
11,090
14,879
8,082
-55
-31
653
653-31-558,08214,87911,090-9,0852,0058121,003960612528335
   > Long-term Liabilities 
3,129
4,129
4,130
3,923
5,100
5,554
5,842
7,568
38,158
56,143
6,853
11,984
11,066
6,463
6,46311,06611,9846,85356,14338,1587,5685,8425,5545,1003,9234,1304,1293,129
> Total Stockholder Equity
2,191
2,602
2,856
4,242
7,676
7,570
8,048
8,158
21,195
7,709
3,993
4,490
4,025
6,683
6,6834,0254,4903,9937,70921,1958,1588,0487,5707,6764,2422,8562,6022,191
   Common Stock
104
193
210
210
232
232
255
255
1,969
1,969
1,969
2,292
2,717
2,892
2,8922,7172,2921,9691,9691,969255255232232210210193104
   Retained Earnings 
553
308
0
131
851
-193
-1,715
-2,072
-32,786
-45,681
-16,849
-19,862
-22,224
-20,650
-20,650-22,224-19,862-16,849-45,681-32,786-2,072-1,715-1938511310308553
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
1,533
2,101
2,988
3,902
6,593
7,531
9,508
16,342
91,432
88,028
92,029
22,060
22,564
23,263
23,26322,56422,06092,02988,02891,43216,3429,5087,5316,5933,9022,9882,1011,533



6.4. Balance Sheets

All numbers in thousands.




6.5. Cash Flows

All numbers in thousands.




6.6. Income Statements

All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,908
Cost of Revenue-451
Gross Profit3,4583,458
 
Operating Income (+$)
Gross Profit3,458
Operating Expense-840
Operating Income2,6542,617
 
Operating Expense (+$)
Research Development1,451
Selling General Administrative458
Selling And Marketing Expenses39
Operating Expense8401,948
 
Net Interest Income (+$)
Interest Income0
Interest Expense-311
Other Finance Cost-311
Net Interest Income0
 
Pretax Income (+$)
Operating Income2,654
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)2,3222,986
EBIT - interestExpense = 2,322
2,322
1,885
Interest Expense311
Earnings Before Interest and Taxes (EBIT)2,6332,633
Earnings Before Interest and Taxes (EBITDA)5,099
 
After tax Income (+$)
Income Before Tax2,322
Tax Provision-0
Net Income From Continuing Ops02,322
Net Income1,574
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,254
Total Other Income/Expenses Net-3320
 

Technical Analysis of Biotechnology Assets S.A.
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biotechnology Assets S.A.. The general trend of Biotechnology Assets S.A. is BULLISH with 71.4% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biotechnology Assets S.A.'s overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (71.4%) Bearish trend (-71.4%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biotechnology Assets S.A..

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.37 < 0.3735 < 0.39.

The bearish price targets are: 0.306 > 0.261 > 0.236.

Tweet this
Biotechnology Assets S.A. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biotechnology Assets S.A.. The current mas is .

The long score for the Moving Averages is 12/14.
The longshort score for the Moving Averages is 10/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biotechnology Assets S.A. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biotechnology Assets S.A.. The current macd is 0.00935032.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biotechnology Assets S.A. price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Biotechnology Assets S.A.. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Biotechnology Assets S.A. price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biotechnology Assets S.A. Daily Moving Average Convergence/Divergence (MACD) ChartBiotechnology Assets S.A. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biotechnology Assets S.A.. The current adx is 30.62.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Biotechnology Assets S.A. shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Biotechnology Assets S.A. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biotechnology Assets S.A.. The current sar is 0.32245017.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Biotechnology Assets S.A. Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biotechnology Assets S.A.. The current rsi is 57.26. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending up: The RSI is trending up. +1
Biotechnology Assets S.A. Daily Relative Strength Index (RSI) ChartBiotechnology Assets S.A. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biotechnology Assets S.A.. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Biotechnology Assets S.A. price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Biotechnology Assets S.A. Daily Stochastic Oscillator ChartBiotechnology Assets S.A. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biotechnology Assets S.A.. The current cci is 51.10.

Biotechnology Assets S.A. Daily Commodity Channel Index (CCI) ChartBiotechnology Assets S.A. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biotechnology Assets S.A.. The current cmo is 15.07.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Biotechnology Assets S.A. Daily Chande Momentum Oscillator (CMO) ChartBiotechnology Assets S.A. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biotechnology Assets S.A.. The current willr is -43.08943089.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biotechnology Assets S.A. is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biotechnology Assets S.A. Daily Williams %R ChartBiotechnology Assets S.A. Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biotechnology Assets S.A..

Biotechnology Assets S.A. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biotechnology Assets S.A.. The current atr is 0.01982697.

Biotechnology Assets S.A. Daily Average True Range (ATR) ChartBiotechnology Assets S.A. Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biotechnology Assets S.A.. The current obv is -3,785,351.

Biotechnology Assets S.A. Daily On-Balance Volume (OBV) ChartBiotechnology Assets S.A. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biotechnology Assets S.A.. The current mfi is 75.68.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Biotechnology Assets S.A. Daily Money Flow Index (MFI) ChartBiotechnology Assets S.A. Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biotechnology Assets S.A..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-09-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-11SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-23STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-10-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-28CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-10-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-12RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-11-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-28CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-12-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-10MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-12-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-12-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-12-20STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-12-24BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-30STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-02WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-01-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-13CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-03STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-02-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-02-11STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-02-14STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Biotechnology Assets S.A. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biotechnology Assets S.A. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5057.259
Ma 20Greater thanMa 500.334
Ma 50Greater thanMa 1000.317
Ma 100Greater thanMa 2000.309
OpenGreater thanClose0.337
Total3/5 (60.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Biotechnology Assets S.A. with someone you think should read this too:
  • Are you bullish or bearish on Biotechnology Assets S.A.? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biotechnology Assets S.A.? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biotechnology Assets S.A.

I send you an email if I find something interesting about Biotechnology Assets S.A..


Comments

How you think about this?

Leave a comment

Stay informed about Biotechnology Assets S.A..

Receive notifications about Biotechnology Assets S.A. in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.